4//SEC Filing
Kariv Tomer 4
Accession 0001209191-21-037795
CIK 0001664710other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 5:31 PM ET
Size
5.6 KB
Accession
0001209191-21-037795
Insider Transaction Report
Form 4
Kariv Tomer
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2021-06-01+8,293→ 8,293 totalExercise: $51.48Exp: 2031-05-31→ Common Stock (8,293 underlying)
Footnotes (1)
- [F1]The option shall vest in equal quarterly installments over the 12 months following the date of grant, provided that the grant will in any case be fully vested on the date of Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Keros Therapeutics, Inc.
CIK 0001664710
Entity typeother
Related Parties
1- filerCIK 0001568077
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 5:31 PM ET
- Size
- 5.6 KB